Topic description and stories

Professor David Thomas and Dr Nicolas Wisniacki

Cambridge and GSK announce new five-year collaboration aiming for improved outcomes for patients with hard-to-treat kidney and respiratory diseases

21 Oct 2024

The ambition of the partnership is to treat immune-related diseases more precisely with existing therapies and to rapidly develop new ones.

Read more

Changemakers in cancer: Oluwasegun Alofaranmi

15 Jul 2024

As a young medical student in Nigeria, Segun was shocked by the disproportionate rate of death from treatable cancers across Africa. To help bring...

Read more

Changemakers in cancer: Swetha Kannan

05 Jun 2024

Swetha was 12 years old when she decided she would help to unravel the mysteries of cancer. Twelve years later, she's studying for a PhD on cancer...

Read more
Close up of a person being injected with a vaccine

‘Ageing’ immune cell levels could predict how well we respond to vaccines

27 Jun 2023

Cambridge scientists have identified a signature in the blood that could help predict how well an individual will respond to vaccines. The discovery...

Read more
Developing immune cells (B cells) from prenatal gut tissue

Immune cell characteristics mapped across multiple tissues

13 May 2022

Previously underexplored immune cell populations have been genetically mapped across multiple tissues to provide new insights into how our immune...

Read more
Tired looking woman

Biological ‘fingerprints’ of long COVID in blood could lead to diagnostic test, say Cambridge scientists

19 Jul 2021

Markers in our blood – ‘fingerprints’ of infection – could help identify individuals who have been infected by SARS-CoV-2, the coronavirus that...

Read more

Likelihood of severe and ‘long’ COVID may be established very early on following infection

18 Jan 2021

New research provides important insights into the role played by the immune system in preventing – and in some cases increasing the severity of –...

Read more
Creative rendition of SARS-COV-2 virus particles

Remdesivir likely to be highly effective antiviral against SARS-CoV-2 for some patients

14 Dec 2020

The drug remdesivir is likely to be a highly effective antiviral against SARS-CoV-2, according to a new study by a team of UK scientists. Writing in...

Read more
Confocal micrograph showing the superior saggital sinus in the mouse. Immune cells are shown in green lining this tube, and blood vessels in red

Why it takes guts to protect the brain against infection

04 Nov 2020

The brain is uniquely protected against invading bacteria and viruses, but its defence mechanism has long remained a mystery. Now, a study in mice...

Read more

“We’re in it for the long haul”

21 Oct 2020

In late 2019, a new institute opened on the Cambridge Biomedical Campus. Its timing could not have been better - as the COVID-19 pandemic sent...

Read more
Academy of Medical Sciences

The Academy of Medical Sciences announces new Fellows for 2020

13 May 2020

Six affiliates of the University of Cambridge are among 50 world-leading UK researchers who have been elected to the prestigious Fellowship of the...

Read more

New innovation hub aims to take a 'moon shot' at cystic fibrosis

18 Apr 2018

Almost 30 years on from the discovery of the genetic defect that causes cystic fibrosis, treatment options are still limited and growing antibiotic...

Read more

Pages